| Effects of child maltreatment and inherited liability on antisocial development: an official records study M Jonson-Reid, N Presnall, B Drake, L Fox, L Bierut, W Reich, P Kane, ... Journal of the American Academy of Child & Adolescent Psychiatry 49 (4), 321-332, 2010 | 95 | 2010 |
| The case for a medication first approach to the treatment of opioid use disorder RP Winograd, N Presnall, E Stringfellow, C Wood, P Horn, A Duello, ... The American Journal of Drug and Alcohol Abuse 45 (4), 333-340, 2019 | 62 | 2019 |
| Implementation and evaluation of Missouri's Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs RP Winograd, CA Wood, EJ Stringfellow, N Presnall, A Duello, P Horn, ... Journal of Substance Abuse Treatment 108, 55-64, 2020 | 45 | 2020 |
| Parent training: equivalent improvement in externalizing behavior for children with and without familial risk N Presnall, CH Webster-Stratton, JN Constantino Journal of the American Academy of Child & Adolescent Psychiatry 53 (8), 879 …, 2014 | 36 | 2014 |
| Association between benzodiazepine or Z-drug prescriptions and drug-related poisonings among patients receiving buprenorphine maintenance: a case-crossover analysis KY Xu, JT Borodovsky, N Presnall, CM Mintz, SM Hartz, LJ Bierut, ... American journal of psychiatry 178 (7), 651-659, 2021 | 28 | 2021 |
| Age disparities in six-month treatment retention for opioid use disorder CM Mintz, NJ Presnall, JM Sahrmann, JT Borodovsky, PEA Glaser, ... Drug and alcohol dependence 213, 108130, 2020 | 23 | 2020 |
| A comparison of buprenorphine and psychosocial treatment outcomes in psychosocial and medical settings NJ Presnall, DAPS Wolf, DS Brown, S Beeler-Stinn, RA Grucza Journal of substance abuse treatment 104, 135-143, 2019 | 21 | 2019 |
| Association of opioid use disorder treatment with alcohol-related acute events KY Xu, N Presnall, CM Mintz, JT Borodovsky, NR Bhat, LJ Bierut, ... JAMA network open 4 (2), e210061-e210061, 2021 | 18 | 2021 |
| Comparative effectiveness associated with buprenorphine and naltrexone in opioid use disorder and cooccurring polysubstance use KY Xu, CM Mintz, N Presnall, LJ Bierut, RA Grucza JAMA network open 5 (5), e2211363-e2211363, 2022 | 16 | 2022 |
| An examination between treatment type and treatment retention in persons with opioid and co-occurring alcohol use disorders CM Mintz, NJ Presnall, KY Xu, SM Hartz, JM Sahrmann, LJ Bierut, ... Drug and alcohol dependence 226, 108886, 2021 | 12 | 2021 |
| Consumer access to buprenorphine and methadone in certified community behavioral health centers: A secret shopper study NJ Presnall, GC Butler, RA Grucza Journal of Substance Abuse Treatment 139, 108788, 2022 | 11 | 2022 |
| Analysis of stimulant prescriptions and drug-related poisoning risk among persons receiving buprenorphine treatment for opioid use disorder CM Mintz, KY Xu, NJ Presnall, SM Hartz, FR Levin, JF Scherrer, LJ Bierut, ... JAMA network open 5 (5), e2211634-e2211634, 2022 | 9 | 2022 |
| Association of bupropion, naltrexone, and opioid agonist treatment with stimulant-related admissions among people with opioid use disorder: a case-crossover analysis KY Xu, CM Mintz, N Presnall, LJ Bierut, RA Grucza The Journal of clinical psychiatry 83 (4), 41504, 2022 | 7 | 2022 |
| Consumer Access to Buprenorphine in Publicly Funded Specialty Treatment Programs for Opioid Use Disorder N Presnall, G Croce Butler, R Grucza Available at SSRN 4139779, 2022 | 2 | 2022 |
| It is illegal to post this copyrighted PDF on any website. KS Ladha J Clin Psychiatry 83 (1), 21r13870, 2022 | 2 | 2022 |
| Corrigendum to “Age disparities in six-month treatment retention for opioid use disorder”[Drug Alcohol Depend. 213 (2020) 108130](Drug and Alcohol Dependence (2020) 213 … CM Mintz, NJ Presnall, JM Sahrmann, JT Borodovsky, PEA Glaser, ... Drug and Alcohol Dependence 216, 108312, 2020 | 1 | 2020 |
| Association of Bupropion, Naltrexone, and Opioid Agonist Treatment with Stimulant-Related Events in Opioid Use Disorder: A Case-Crossover Analysis K Xu, C Mintz, N Presnall, L Bierut, R Grucza AMERICAN JOURNAL ON ADDICTIONS 31 (4), 364-365, 2022 | | 2022 |
| Associations between Stimulant Prescriptions and Drug-related Poisoning Risk among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder C Mintz, K Xu, N Presnall, S Hartz, F Levin, J Scherrer, L Bierut, R Grucza AMERICAN JOURNAL ON ADDICTIONS 31 (4), 353-354, 2022 | | 2022 |
| Medication Improves Age Disparities in Six-Month Treatment Retention for Opioid Use Disorder CM Mintz, NJ Presnall, JM Sahrmann, JT Borodovsky, PEA Glaser, ... medRxiv, 2020.02. 21.20023143, 2020 | | 2020 |
